Nuwellis (NUWE)
0.78
+0.05 (6.85%)
Upcoming Events
Latest Headlines
Form EFFECT Nuwellis, Inc.
August 27, 2026 6:07 AM - SEC Filing
Form 424B3 Nuwellis, Inc.
August 26, 2026 5:15 PM - SEC Filing
Form 8-K Nuwellis, Inc. For: Aug 25
August 26, 2026 6:04 AM - SEC Filing
Nuwellis strikes co-promotion deal with Atrility Medical for AtriAmp
August 25, 2026 8:32 AM - StreetInsider
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
August 25, 2026 8:30 AM - Globe NewsWire
Form S-3 Nuwellis, Inc.
August 18, 2026 4:42 PM - SEC Filing
Form SCHEDULE 13G/A Nuwellis, Inc. Filed by: ARMISTICE CAPITAL, LLC
August 14, 2026 10:23 AM - SEC Filing
Form 8-K Nuwellis, Inc. For: Aug 13
August 13, 2026 4:39 PM - SEC Filing
Form 10-Q Nuwellis, Inc. For: Jun 30
August 13, 2026 4:08 PM - SEC Filing
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin
August 13, 2026 8:00 AM - Globe NewsWire
Nuwellis announces EHR connectivity program for Aquadex platform
August 11, 2026 5:56 AM - StreetInsider
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface
August 11, 2026 3:30 AM - Globe NewsWire
Form SCHEDULE 13G Nuwellis, Inc. Filed by: Orca Capital AG
August 7, 2026 5:00 PM - SEC Filing
Form SCHEDULE 13G Nuwellis, Inc. Filed by: INTRACOASTAL CAPITAL, LLC
August 6, 2026 5:14 PM - SEC Filing
Nuwellis names Dale Brady as principal R&D engineer
August 6, 2026 8:32 AM - StreetInsider
Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer
August 6, 2026 8:30 AM - Globe NewsWire
Form SCHEDULE 13G Nuwellis, Inc. Filed by: Lind Global Fund III LP
August 5, 2026 5:15 PM - SEC Filing
Nuwellis plans to expand Aquadex system into broader therapy platform
August 4, 2026 8:31 AM - StreetInsider
Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications
August 4, 2026 8:30 AM - Globe NewsWire
Form 8-K Nuwellis, Inc. For: Jul 31
August 3, 2026 4:36 PM - SEC Filing
Form 424B5 Nuwellis, Inc.
August 3, 2026 7:27 AM - SEC Filing
Nuwellis prices $3.4M direct offering at $2.59 per share
July 31, 2026 8:39 AM - StreetInsider
Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
July 31, 2026 8:39 AM - Globe NewsWire
Study supports epoprostenol as anticoagulant in pediatric Aquadex therapy
July 30, 2026 8:02 AM - StreetInsider
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
July 30, 2026 8:00 AM - Globe NewsWire
Nuwellis installs Aquadex SmartFlow systems in Wisconsin
July 28, 2026 8:00 AM - StreetInsider
Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin
July 28, 2026 8:00 AM - Globe NewsWire
Nuwellis reports preliminary 14% revenue growth in Q2 2026
July 27, 2026 8:36 AM - StreetInsider
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth
July 27, 2026 8:30 AM - Globe NewsWire
Form 8-K Nuwellis, Inc. For: Jul 24
July 24, 2026 4:16 PM - SEC Filing
Nuwellis receives U.S. patent for dual lumen catheter design
July 16, 2026 8:33 AM - StreetInsider
Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies
July 16, 2026 8:30 AM - Globe NewsWire
Form DEF 14A Nuwellis, Inc. For: Jul 07
July 7, 2026 4:30 PM - SEC Filing
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
July 7, 2026 8:00 AM - Globe NewsWire
Form 3 Nuwellis, Inc. For: Jun 30 Filed by: McCormick Michael Kendrick
July 1, 2026 4:15 PM - SEC Filing
Form PRE 14A Nuwellis, Inc. For: Jul 24
June 26, 2026 5:12 PM - SEC Filing
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)
June 26, 2026 8:00 AM - Globe NewsWire
Nuwellis installs Aquadex systems at Michigan pediatric facility
June 25, 2026 8:31 AM - StreetInsider
Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations
June 25, 2026 8:30 AM - Globe NewsWire
Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders
June 24, 2026 8:30 AM - Globe NewsWire
Form 8-K Nuwellis, Inc. For: Jun 23
June 24, 2026 6:02 AM - SEC Filing
Nuwellis trains 280+ physicians on Aquadex at Minnesota summit
June 18, 2026 8:30 AM - StreetInsider
Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit
June 18, 2026 8:30 AM - Globe NewsWire
Form 8-K Nuwellis, Inc. For: Jun 16
June 18, 2026 6:02 AM - SEC Filing
Nuwellis names Mike McCormick as CEO, effective June 30
June 16, 2026 8:34 AM - StreetInsider
Nuwellis Appoints Mike McCormick as Chief Executive Officer
June 16, 2026 8:30 AM - Globe NewsWire
Form 8-K Nuwellis, Inc. For: Jun 08
June 10, 2026 9:10 AM - SEC Filing
Nuwellis expands Aquadex device deployment to South Carolina children's hospital
June 10, 2026 8:33 AM - StreetInsider
Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals
June 10, 2026 8:30 AM - Globe NewsWire
Nuwellis closes $6 million public offering of stock and warrants
June 8, 2026 9:46 PM - StreetInsider
Nuwellis Announces Closing of $6.0 Million Registered Public Offering
June 8, 2026 9:46 PM - Globe NewsWire
Form 424B4 Nuwellis, Inc.
June 8, 2026 9:04 AM - SEC Filing
Full Article List
